Restoration of glucokinase expression in the liver normalizes postprandial glucose disposal in mice with hepatic deficiency of PDK1

被引:32
作者
Okamoto, Yasuo
Ogawa, Wataru [1 ]
Nishizawa, Akihiko
Inoue, Hiroshi
Teshigawara, Kiyoshi
Kinoshita, Shinichi
Matsuki, Yasushi
Watanabe, Eijiro
Hiramatsu, Ryuji
Sakaue, Hiroshi
Noda, Tetsuo
Kasuga, Masato
机构
[1] Kobe Univ, Grad Sch Med, Div Diabet & Digest & Kidney Dis, Dept Clin Mol Med, Kobe, Hyogo 6570011, Japan
[2] Danippon Sumitomo Pharmaceut, Genom Sci Labs, Takarazuka, Hyogo, Japan
[3] Inst Canc Res, JFCR, Dept Cell Biol, Tokyo, Japan
关键词
INSULIN-RECEPTOR SUBSTRATE-1; PEPCK GENE-EXPRESSION; THREONINE KINASE AKT; PHOSPHOINOSITIDE; 3-KINASE; CRE RECOMBINASE; PHOSPHORYLATION; METABOLISM; CELLS; HEPATOCYTES; SENSITIVITY;
D O I
10.2337/db06-1322
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Phosphoinositide-dependent kinase-1 (PDK1) is implicated in the metabolic effects of insulin as a key mediator of phosphoinositide 3-kinase-dependent signaling. Here we show that mice with liver-specific PDK1 deficiency manifest various defects in the metabolic actions of insulin in the liver as well as a type 2 diabetes-like phenotype characterized by marked hyperinsulinemia and postprandial hyperglycemia. The hepatic abundance of glucokinase, an important determinant of glucose flux and glucose-evoked signaling in hepatocytes, was substantially reduced in these mice. Restoration of hepatic glucokinase expression, with the use of an adenoviral vector, induced insulin-like effects in the liver and almost completely normalized the fasting hyperinsulinemia and postprandial hyperglycemia in these animals. These results indicate that, if the hepatic abundance of glucokinase is maintained, ingested glucose is normally disposed of even in the absence of acute activation of proximal insulin signaling, such as the activation of Akt, in the liver.
引用
收藏
页码:1000 / 1009
页数:10
相关论文
共 34 条
[1]   INHIBITION OF GLYCOGEN-SYNTHASE KINASE-3 BY INSULIN-MEDIATED BY PROTEIN-KINASE-B [J].
CROSS, DAE ;
ALESSI, DR ;
COHEN, P ;
ANDJELKOVICH, M ;
HEMMINGS, BA .
NATURE, 1995, 378 (6559) :785-789
[2]   Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression [J].
Dentin, R ;
Pégorier, JP ;
Benhamed, F ;
Foufelle, F ;
Ferré, P ;
Fauveau, V ;
Magnuson, MA ;
Girard, J ;
Postic, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (19) :20314-20326
[3]  
DOHERTY RM, 1998, DIABETES, V48, P2022
[4]   Evidence from transgenic mice that glucokinase is rate limiting for glucose utilization in the liver [J].
Ferre, T ;
Riu, E ;
Bosch, F ;
Valera, A .
FASEB JOURNAL, 1996, 10 (10) :1213-1218
[5]   Correction of diabetic alterations by glucokinase [J].
Ferre, T ;
Pujol, A ;
Riu, E ;
Bosch, F ;
Valera, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (14) :7225-7230
[6]  
GRANNER DK, 2005, JOSLINS DIABETES MEL, P244
[7]   Ablation of PDK1 in pancreatic β cells induces diabetes as a result of loss of β cell mass [J].
Hashimoto, N ;
Kido, Y ;
Uchida, T ;
Asahara, SI ;
Shigeyama, Y ;
Matsuda, T ;
Takeda, A ;
Tsuchihashi, D ;
Nishizawa, A ;
Ogawa, W ;
Fujimoto, Y ;
Okamura, H ;
Arden, KC ;
Herrera, PL ;
Noda, T ;
Kasuga, M .
NATURE GENETICS, 2006, 38 (05) :589-593
[8]   Role of hepatic STAT3 in brain-insulin action on hepatic glucose production [J].
Inoue, H ;
Ogawa, W ;
Asakawa, A ;
Okamoto, Y ;
Nishizawa, A ;
Matsumoto, M ;
Teshigawara, K ;
Matsuki, Y ;
Watanabe, E ;
Hiramatsu, R ;
Notohara, K ;
Katayose, K ;
Okamura, H ;
Kahn, CR ;
Noda, T ;
Takeda, K ;
Akira, S ;
Inui, A ;
Kasuga, M .
CELL METABOLISM, 2006, 3 (04) :267-275
[9]   Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo [J].
Inoue, H ;
Ogawa, W ;
Ozaki, M ;
Haga, S ;
Matsumoto, M ;
Furukawa, K ;
Hashimoto, N ;
Kido, Y ;
Mori, T ;
Sakaue, H ;
Teshigawara, K ;
Jin, SY ;
Iguchi, H ;
Hiramatsu, R ;
LeRoith, D ;
Takeda, K ;
Akira, S ;
Kasuga, M .
NATURE MEDICINE, 2004, 10 (02) :168-174
[10]  
Kellendonk C, 2000, GENESIS, V26, P151, DOI 10.1002/(SICI)1526-968X(200002)26:2<151::AID-GENE17>3.0.CO